Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Natl Oilwell Varco (NY:NOV)

13.97 +0.26 (+1.90%)
Official Closing Price Updated: 7:00 PM EDT, Jul 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Natl Oilwell Varco

< Previous 1 2 3 4 5 6 Next >
3 Sorry Energy Stocks to Sell in May Before It’s Too Late
These energy stocks to sell are at risk of experiencing considerable downside in the near future due to the deteriorating market conditions 
Via InvestorPlace
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against NOV Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
Expert Ratings for NOV
 
Via Benzinga
NOV Reports First Quarter 2023 Earnings
From NOV Inc.
Via Business Wire
Where NOV Stands With Analysts
 
Via Benzinga
What 6 Analyst Ratings Have To Say About NOV
 
Via Benzinga
Earnings Preview: NOV
 
Via Benzinga
Analyst Ratings for NOV
 
Via Benzinga
Expert Ratings for NOV
Analysts have provided the following ratings for NOV (NYSE:NOV) within the last quarter: 
Via Benzinga
NOV Announces First Quarter 2023 Earnings Conference Call
From NOV Inc.
Via Business Wire
NOV Declares Regular Quarterly Dividend
From NOV Inc.
Via Business Wire
3 Midcap Energy Stocks Set For Triple-Digit Earnings Growth
While top oil-and-gas giants get the lion’s share of attention, mid-caps NOV, Weatherford, and HighPeak are on track to grow earnings at triple-digit rates. 
Via MarketBeat
NOV Reports Fourth Quarter and Full Year 2022 Results
From NOV Inc.
Via Business Wire
Analyst Ratings for NOV
NOV (NYSE:NOV) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Earnings Scheduled For February 6, 2023
Companies Reporting Before The Bell • Cummins (NYSE:CMI) is projected to report quarterly earnings at $4.56 per share on revenue of $7.21 billion. 
Via Benzinga
Novavax Shares Jumped in January While Others Slipped
Updated FDA Covid vaccine policy could've boosted NVAX shares at the end of January, when other pharma stocks slipped, but it may not affect the bottom line. 
Via MarketBeat
Does Oil Services Firm NOV Have Enough Energy To Maintain Rally?
The energy boom is back, and oil-and-gas industry supplier NOV is capitalizing on the uptrend. The stock's January performance outpaced the broader industry. 
Via MarketBeat
Topics Supply Chain
Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2023
 
Via Benzinga
Four Undervalued Healthcare Stocks for 2023
These four health care stocks could be undervalued: Pfizer Inc., Regeneron Pharmaceuticals Inc., Innoviva Inc. and Exelixis Inc. 
Via MarketBeat
Benzinga's Top Ratings Upgrades, Downgrades For January 4, 2023
 
Via Benzinga
Starbucks To Rally 11%? Here Are 10 Other Analyst Forecasts For Wednesday
UBS cut Microsoft Corporation (NASDAQ: MSFT) price target from $300 to $250. UBS analyst Karl Keirstead downgraded the stock from Buy to Neutral. Microsoft shares fell 2% to $234.73 in pre-market... 
Via Benzinga
NOV Announces Fourth Quarter and Full Year 2022 Earnings Conference Call
From NOV Inc.
Via Business Wire
NOV Declares Regular Quarterly Dividend
From NOV Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For November 7, 2022
Upgrades 
Via Benzinga
Block To 100? Plus This Analyst Slashes PT On Estée Lauder By 32%
  Barclays slashed the price target on Block, Inc. (NYSE: SQ) from $130 to $100. Block shares rose 1% to $60.70 in pre-market trading. 
Via Benzinga
Data and Fed Sets Up Explosive Week
Via Talk Markets
NOV Reports Third Quarter 2022 Earnings
From NOV Inc.
Via Business Wire
Earnings Outlook For NOV
NOV (NYSE:NOV) is set to give its latest quarterly earnings report on Thursday, 2022-10-27. Here's what investors need to know before the announcement. Analysts estimate that NOV will report an... 
Via Benzinga
Is 2023 The 'Trickle-Down Year' For NOV? Why This Wall Street Analyst Is Bullish
Bank Of America analyst Chase Mulvehill upgraded NOV (NYSE: NOV) with a price target of $19. Key Takeaways: "Trickle-down on the move; upgrade to Buy," Mulvehill said in a note.  
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022
Upgrades 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS